Literature DB >> 11126427

Role of micronutrients in HIV-infected intravenous drug users.

M K Baum1.   

Abstract

Nutritional deficiencies are widespread among HIV-1-seropositive male and female drug abusers (injecting drug users, or IDUs), among men who have sex with men (MSM), and among children, although the prevalence of nutritional alterations varies among the groups. Low levels of vitamin A, vitamin B12, zinc, and selenium are common and have been demonstrated to be associated with disease progression and HIV-1 related mortality, independent of CD4 count <200 cells/mm3 at baseline and CD4 count over time. When all nutrient factors that are associated with survival are considered together, only selenium deficiency is a significant predictor of mortality. The profound effect of selenium on disease progression may reflect selenium's action in antioxidant defense systems, as well as gene regulation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11126427     DOI: 10.1097/00042560-200010001-00008

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  13 in total

1.  Coinfection with hepatitis C virus, oxidative stress and antioxidant status in HIV-positive drug users in Miami.

Authors:  M K Baum; S Sales; D T Jayaweera; S Lai; G Bradwin; C Rafie; J B Page; A Campa
Journal:  HIV Med       Date:  2011-02       Impact factor: 3.180

2.  Relationship between hunger, adherence to antiretroviral therapy and plasma HIV RNA suppression among HIV-positive illicit drug users in a Canadian setting.

Authors:  Aranka Anema; Thomas Kerr; M-J Milloy; Cindy Feng; Julio S G Montaner; Evan Wood
Journal:  AIDS Care       Date:  2013-09-09

3.  Prevalence and predictors of low muscle mass in HIV/viral hepatitis coinfection.

Authors:  Charitha Gowda; Todd T Brown; Charlene Compher; Kimberly A Forde; Jay Kostman; Pamela A Shaw; Phyllis C Tien; Vincent Lo Re
Journal:  AIDS       Date:  2016-10-23       Impact factor: 4.177

Review 4.  Selenium and selenoproteins in prostanoid metabolism and immunity.

Authors:  Fenghua Qian; Sougat Misra; K Sandeep Prabhu
Journal:  Crit Rev Biochem Mol Biol       Date:  2020-01-30       Impact factor: 8.250

5.  Effect of micronutrient supplementation on disease progression in asymptomatic, antiretroviral-naive, HIV-infected adults in Botswana: a randomized clinical trial.

Authors:  Marianna K Baum; Adriana Campa; Shenghan Lai; Sabrina Sales Martinez; Lesedi Tsalaile; Patricia Burns; Mansour Farahani; Yinghui Li; Erik van Widenfelt; John Bryan Page; Hermann Bussmann; Wafaie W Fawzi; Sikhulele Moyo; Joseph Makhema; Ibou Thior; Myron Essex; Richard Marlink
Journal:  JAMA       Date:  2013-11-27       Impact factor: 56.272

6.  Hunger and associated harms among injection drug users in an urban Canadian setting.

Authors:  Aranka Anema; Evan Wood; Sheri D Weiser; Jiezhi Qi; Julio Sg Montaner; Thomas Kerr
Journal:  Subst Abuse Treat Prev Policy       Date:  2010-08-26

Review 7.  Medical consequences of drug abuse and co-occurring infections: research at the National Institute on Drug Abuse.

Authors:  Jag H Khalsa; Glenn Treisman; Elinore McCance-Katz; Ellen Tedaldi
Journal:  Subst Abus       Date:  2008       Impact factor: 3.716

8.  Effect of GSTM1-Polymorphism on Disease Progression and Oxidative Stress in HIV Infection: Modulation by HIV/HCV Co-Infection and Alcohol Consumption.

Authors:  Mary Parsons; Adriana Campa; Shenghan Lai; Yinghui Li; Janet Diaz Martinez; Jorge Murillo; Pedro Greer; Sabrina Sales Martinez; Marianna K Baum
Journal:  J AIDS Clin Res       Date:  2013-08-31

9.  Nutrition issues in chronic drug users living with HIV infection.

Authors:  Kristy Hendricks; Sherwood Gorbach
Journal:  Addict Sci Clin Pract       Date:  2009-04

10.  Relationship between food insecurity and mortality among HIV-positive injection drug users receiving antiretroviral therapy in British Columbia, Canada.

Authors:  Aranka Anema; Keith Chan; Yalin Chen; Sheri Weiser; Julio S G Montaner; Robert S Hogg
Journal:  PLoS One       Date:  2013-05-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.